Wells Fargo & Company Uni Qure N.V. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Uni Qure N.V. stock. As of the latest transaction made, Wells Fargo & Company holds 10,856 shares of QURE stock, worth $61,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,856

Previous 11,207 3.13%

Holding current value

$61,336

Previous $58,000 17.24%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.39 - $5.43 $1,540 - $1,905	-351 Reduced 3.13%	10,856 $48,000
Q1 2024 May 10, 2024	BUY	$4.82 - $6.93 $10,266 - $14,760	2,130 Added 23.47%	11,207 $58,000
Q4 2023 Feb 09, 2024	SELL	$5.63 - $8.27 $463,354 - $680,629	-82,301 Reduced 90.07%	9,077 $61,000
Q3 2023 Nov 13, 2023	BUY	$6.71 - $11.83 $269,178 - $474,572	40,116 Added 78.26%	91,378 $613,000
Q2 2023 Aug 15, 2023	BUY	$11.12 - $22.2 $6,082 - $12,143	547 Added 1.08%	51,262 $587,000
Q1 2023 May 12, 2023	BUY	$18.7 - $23.07 $711,385 - $877,628	38,042 Added 300.18%	50,715 $1.02 Million
Q4 2022 Feb 13, 2023	SELL	$18.12 - $27.32 $65,268 - $98,406	-3,602 Reduced 22.13%	12,673 $287,000
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $91,624 - $137,813	-5,396 Reduced 24.9%	16,275 $306,000
Q2 2022 Aug 12, 2022	BUY	$13.15 - $20.45 $20,737 - $32,249	1,577 Added 7.85%	21,671 $403,000
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $72,365 - $107,005	4,977 Added 32.92%	20,094 $362,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $3.56 Million - $6.33 Million	-175,866 Reduced 92.08%	15,117 $313,000
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $4.49 Million - $6.59 Million	172,503 Added 933.46%	190,983 $6.11 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $779 - $966	-26 Reduced 0.14%	18,480 $569,000
Q1 2021 May 13, 2021	SELL	$29.24 - $42.03 $635,472 - $913,437	-21,733 Reduced 54.01%	18,506 $623,000
Q4 2020 Feb 09, 2021	BUY	$35.35 - $50.67 $303,373 - $434,849	8,582 Added 27.11%	40,239 $1.46 Million
Q3 2020 Nov 05, 2020	BUY	$35.98 - $47.66 $79,335 - $105,090	2,205 Added 7.49%	31,657 $1.17 Million
Q2 2020 Aug 13, 2020	SELL	$45.06 - $67.74 $177,446 - $266,760	-3,938 Reduced 11.79%	29,452 $1.33 Million
Q1 2020 May 14, 2020	BUY	$40.01 - $73.97 $1.34 Million - $2.47 Million	33,390 New	33,390 $1.59 Million

Others Institutions Holding QURE

# of Institutions

140

Shares Held

33.7M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $264M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Uni Qure N.V. Transaction History